Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
RecruitingNot a traditional drug phaseinterventionalRules rewrite
Not a traditional drug phase: IMT and exercise training group for Inspiratory Muscle Training
Recovery after lung transplantation (LTx) may be complicated by prolonged mechanical ventilation (MV) and protracted intensive care unit (ICU) stay leading to immobilization and impaired health-related quality of life (HRQoL). In the critical care setting, diaphragm atrophy and weakness have been associated with difficulty weaning from MV, increased risk for readmission to hospital or ICU, and increased mortality.
This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.
Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
What the registry says happens
If you join, the listed intervention(s) are IMT and exercise training group. The registry lists allocation as randomized. Recovery after lung transplantation (LTx) may be complicated by prolonged mechanical ventilation (MV) and protracted intensive care unit (ICU) stay leading to immobilization and impaired health-related quality of life (HRQoL).
They plan to enroll about 90 people at 4 sites. Taking part typically means study visits and measurements plus check-ins.
Official title (unrewritten)
Inspiratory Muscle Training in Lung Transplant Candidates and Implications on Early Post-Transplant Outcomes: A Pilot and Feasibility Multicenter Randomized Clinical Trial
Interventions: IMT and exercise training group
Primary outcome (registry wording): Study Recruitment According to Research Team Records
Who it is for (from inclusion criteria)
Ages 18 Years to any
Adult participants (≥ 18 years of age)
Lung Transplant Candidates
Participating in outpatient pulmonary rehabilitation (standard of care)
Diagnosis of Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease
Who the registry excludes
Respiratory exacerbation within the last 1 month
Neurologic or musculoskeletal conditions that may interfere with IMT or functional assessments (i.e. history of stroke, severe arthritis of hands)
Any evidence of pneumothorax on recent imaging (\< 6 months)
Present ruptures of eardrums or infections leading to fluid behind ear drum
Marked left or right ventricular end-diastolic volume and pressure overload on right heart catheterization or echocardiogram
Severe osteoporosis with history of rib fractures
Cardiac pacemaker or other electronic or magnetic body implant
This study wants to obtain biologic materials from the blood, airways and/or urine of normal individuals and individuals with lung disease. The normal are used to establish a set of normal ranges for various parameters.
In the context of pulmonary rehabilitation of COPD patients, recent guidelines and metanalysis describe that Resistance Training (RT) can be successfully performed alone or in conjunction with Endurance Training (ET) without evidence of side effects. Maximal Strength Training (MST) is a kind of RT typically performed at \~85-90% of 1RM with maximal velocity to be developed in the concentric phase.
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern.
The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.
What phase is NCT06370832?
Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.
Can PlainTrials tell me if I qualify for NCT06370832?
No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.